Opus Genetics, Inc. · NASDAQ:IRD
Foundation Fighting Blindness Retinal Degeneration Fund reported a 4.66% stake in Opus Genetics, Inc. (Schedule 13D/A)
Event May 18, 2026 · Filed May 20, 2026
Foundation Fighting Blindness Retinal Degeneration Fund reported a 4.66% stake in Opus Genetics, Inc., 3,792,171 shares, with active intent on May 18, 2026. Filed May 20, 2026 (Schedule 13D/A).
- Stake
- 4.66%
- Shares
- 3,792,171
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | 4.66% | 3,792,171 |
| Foundation Fighting Blindness, Inc. | 4.66% | 3,792,171 |
Source
Related
- Opus Genetics, Inc.
- Foundation Fighting Blindness Retinal Degeneration Fund
- Opus Genetics, Inc. shareholders
- Schedule 13D/A · Foundation Fighting Blindness Retinal Degeneration Fund · Dec 11, 2025
- Schedule 13D/A · Foundation Fighting Blindness Retinal Degeneration Fund · May 6, 2025
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026